Chris M. Gonzalez, MD, MBA, FACS, defines the prevalence of lichen sclerosus related urethral strictures in men and other common risks. He explains best practices for managing the disease in order to reduce complications and recurrences, and to improve urinary and sexual function outcomes.
Read More
Larissa V. Rodriguez, MD, summarizes the current understanding and available options of stem cell therapy in the context of female pelvic medicine and reconstruction, especially for treating stress urinary incontinence (SUI), pelvic organ prolapse, interstitial cystitis, and fecal incontinence.
Read More
Chris Gonzalez, MD, MBA, FACS, discusses the development of Patient Reported Outcome Measures (PROMs) to evaluate patient-perceived success of urethral stricture treatments. He describes the Male Sexual Health Questionnaire (MSHQ) and the International Index of Erectile Function (IIEF) and the needed improvement in these types of questionnaires in the future.
Read More
Tobias S. Kohler, MD, MPH, discusses limitations and biases in literature regarding inflatable penile prosthesis (IPP), and how they led to the development of the Prospective Registry of Outcomes With Penile Prosthesis (PROPPER) study and the upcoming Erectile Restoration Outcomes Study (EROS). He describes best practices when performing penile implant surgery, such as infection control, reservoir replacement, wound closure, and patient selection.
Read More
Peter Schulam MD, PhD, compares and contrasts the Surveillance, Epidemiology, and End Results (SEER) database and the National Cancer Database (NCDB) in terms of reliability for assessing upper tract urothelial carcinoma (UTUC) outcomes and risk factors when determining whether to treat a patient with definitive therapy or the “Watchful Waiting” strategy.
Read More